{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:51:48Z","timestamp":1790833908114,"version":"4.1.0"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T00:00:00Z","timestamp":1570147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1002928","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T13:22:52Z","timestamp":1570195372000},"page":"e1002928","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3359-5632","authenticated-orcid":true,"given":"Robert J.","family":"Commons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2660-2013","authenticated-orcid":true,"given":"Julie A.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7536-7497","authenticated-orcid":true,"given":"Kamala","family":"Thriemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tesfay","family":"Abreha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5031-7741","authenticated-orcid":true,"given":"Ishag","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas M.","family":"Anstey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6093-6685","authenticated-orcid":true,"given":"Ashenafi","family":"Assefa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghulam R.","family":"Awab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Kevin","family":"Baird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1066-7960","authenticated-orcid":true,"given":"Bridget E.","family":"Barber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9465-8214","authenticated-orcid":true,"given":"Cindy S.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2158-846X","authenticated-orcid":true,"given":"Prabin","family":"Dahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Daher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0749-7411","authenticated-orcid":true,"given":"Timothy M. E.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5190-2395","authenticated-orcid":true,"given":"Arjen M.","family":"Dondorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9914-8352","authenticated-orcid":true,"given":"Matthew J.","family":"Grigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9947-0034","authenticated-orcid":true,"given":"Georgina S.","family":"Humphreys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimee","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harin","family":"Karunajeewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0964-805X","authenticated-orcid":true,"given":"Moses","family":"Laman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0436-2239","authenticated-orcid":true,"given":"Kartini","family":"Lidia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9792-7838","authenticated-orcid":true,"given":"Brioni R.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7951-0745","authenticated-orcid":true,"given":"Francois","family":"Nosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3830-8073","authenticated-orcid":true,"given":"Ayodhia P.","family":"Pasaribu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7761-5498","authenticated-orcid":true,"given":"Dhelio B.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0383-9624","authenticated-orcid":true,"given":"Aung P.","family":"Phyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1573-734X","authenticated-orcid":true,"given":"Jeanne R.","family":"Poespoprodjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol H.","family":"Sibley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasia","family":"Stepniewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Sutanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Thwaites","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran T.","family":"Hien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1897-1978","authenticated-orcid":true,"given":"Nicholas J.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"William","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5134-7165","authenticated-orcid":true,"given":"Charles J.","family":"Woodrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6008-2963","authenticated-orcid":true,"given":"Philippe J.","family":"Guerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2000-2874","authenticated-orcid":true,"given":"Ric N.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,10,4]]},"reference":[{"issue":"10","key":"pmed.1002928.ref001","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S1473-3099(14)70855-2","article-title":"Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis","volume":"14","author":"RN Price","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"pmed.1002928.ref002","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1475-2875-10-297","article-title":"Determinants of relapse periodicity in Plasmodium vivax malaria","volume":"10","author":"NJ White","year":"2011","journal-title":"Malar J"},{"key":"pmed.1002928.ref003","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1038\/psp.2014.29","article-title":"Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand","volume":"3","author":"J Tarning","year":"2014","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"7","key":"pmed.1002928.ref004","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02476-17","article-title":"Characterizing Blood-Stage Antimalarial Drug MIC Values In Vivo Using Reinfection Patterns","volume":"62","author":"J Watson","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"pmed.1002928.ref005","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4269\/ajtmh.2003.68.416","article-title":"Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua","volume":"68","author":"IW Sumawinata","year":"2003","journal-title":"Am J Trop Med Hyg"},{"issue":"24","key":"pmed.1002928.ref006","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0804915","article-title":"A trial of combination antimalarial therapies in children from Papua New Guinea","volume":"359","author":"HA Karunajeewa","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"pmed.1002928.ref007","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.trstmh.2006.06.008","article-title":"Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia","volume":"101","author":"A Ratcliff","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pmed.1002928.ref008","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/B978-0-12-397900-1.00005-0","article-title":"Chemotherapeutic strategies for reducing transmission of Plasmodium vivax malaria","volume":"80","author":"NM Douglas","year":"2012","journal-title":"Adv Parasitol"},{"key":"pmed.1002928.ref009","article-title":"The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis","author":"RJ Commons","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"pmed.1002928.ref010","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1473-3099(10)70079-7","article-title":"Artemisinin combination therapy for vivax malaria","volume":"10","author":"NM Douglas","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"pmed.1002928.ref011","doi-asserted-by":"crossref","DOI":"10.30875\/50d27d62-en","volume-title":"World Malaria Report 2017","author":"World Health Organization","year":"2017"},{"key":"pmed.1002928.ref012","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1475-2875-13-144","article-title":"Geographical variation in Plasmodium vivax relapse","volume":"13","author":"KE Battle","year":"2014","journal-title":"Malar J"},{"issue":"12","key":"pmed.1002928.ref013","doi-asserted-by":"crossref","first-page":"e1001575","DOI":"10.1371\/journal.pmed.1001575","article-title":"Major burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance study","volume":"10","author":"NM Douglas","year":"2013","journal-title":"PLoS Med"},{"issue":"12","key":"pmed.1002928.ref014","doi-asserted-by":"crossref","first-page":"e1325","DOI":"10.1371\/journal.pntd.0001325","article-title":"The use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malaria","volume":"5","author":"Q. Bassat","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"pmed.1002928.ref015","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/cid\/ciq249","article-title":"Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics","volume":"52","author":"NM Douglas","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"2","key":"pmed.1002928.ref016","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpddr.2017.03.003","article-title":"The Vivax Surveyor: Online mapping database for Plasmodium vivax clinical trials","volume":"7","author":"RJ Commons","year":"2017","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"pmed.1002928.ref017","volume-title":"Data Management and Statistical Analysis Plan v1.2","author":"WorldWide Antimalarial Resistance Network","year":"2012"},{"key":"pmed.1002928.ref018","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/1475-2875-11-280","article-title":"Primaquine radical cure of Plasmodium vivax: a critical review of the literature","volume":"11","author":"GK John","year":"2012","journal-title":"Malar J"},{"key":"pmed.1002928.ref019","volume-title":"Guidelines for the treatment of malaria","author":"World Health Organisation","year":"2015"},{"issue":"1","key":"pmed.1002928.ref020","doi-asserted-by":"crossref","first-page":"e1002212","DOI":"10.1371\/journal.pmed.1002212","article-title":"Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis","volume":"14","author":"RM Hoglund","year":"2017","journal-title":"PLoS Med"},{"issue":"12","key":"pmed.1002928.ref021","doi-asserted-by":"crossref","first-page":"e1001564","DOI":"10.1371\/journal.pmed.1001564","article-title":"The effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient data","volume":"10","author":"WorldWide Antimalarial Resistance Network DPSG","year":"2013","journal-title":"PLoS Med"},{"key":"pmed.1002928.ref022","volume-title":"Statistical Analysis Plan: WWARN Vivax Recurrence Study Group v0.2","author":"WorldWide Antimalarial Resistance Network","year":"2016"},{"issue":"7","key":"pmed.1002928.ref023","doi-asserted-by":"crossref","first-page":"e1001855","DOI":"10.1371\/journal.pmed.1001855","article-title":"Individual Participant Data (IPD) Meta-analyses of Randomised Controlled Trials: Guidance on Their Use","volume":"12","author":"JF Tierney","year":"2015","journal-title":"PLoS Med"},{"issue":"6","key":"pmed.1002928.ref024","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S1473-3099(15)70024-1","article-title":"The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data","volume":"15","author":"Worldwide Antimalarial Resistance Network ALDISG","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"pmed.1002928.ref025","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1086\/512677","article-title":"Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria","volume":"44","author":"AR Hasugian","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"9563","key":"pmed.1002928.ref026","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(07)60160-3","article-title":"Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison","volume":"369","author":"A Ratcliff","year":"2007","journal-title":"Lancet"},{"issue":"10","key":"pmed.1002928.ref027","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/cid\/cir631","article-title":"Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial","volume":"53","author":"AP Phyo","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"3","key":"pmed.1002928.ref028","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/cid\/cis902","article-title":"A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy","volume":"56","author":"BE Barber","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"11","key":"pmed.1002928.ref029","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1093\/infdis\/jit407","article-title":"A randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine combined with primaquine for radical treatment of vivax malaria in Sumatera, Indonesia","volume":"208","author":"AP Pasaribu","year":"2013","journal-title":"J Infect Dis"},{"issue":"3","key":"pmed.1002928.ref030","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1128\/AAC.01879-12","article-title":"Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia","volume":"57","author":"I Sutanto","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"pmed.1002928.ref031","doi-asserted-by":"crossref","first-page":"e1001773","DOI":"10.1371\/journal.pmed.1001773","article-title":"Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trial","volume":"11","author":"M Laman","year":"2014","journal-title":"PLoS Med"},{"issue":"2","key":"pmed.1002928.ref032","first-page":"247","article-title":"Therapeutic effects of dihydroartemisinin piperaquine versus chloroquine for uncomplicated vivax malaria in Kupang, East Nusa Tenggara, Indonesia","volume":"31","author":"K Lidia","year":"2015","journal-title":"Int J Pharm Sci Rev Res"},{"key":"pmed.1002928.ref033","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12916-015-0535-9","article-title":"Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia","volume":"13","author":"EJ Nelwan","year":"2015","journal-title":"BMC Med"},{"issue":"4","key":"pmed.1002928.ref034","doi-asserted-by":"crossref","first-page":"879","DOI":"10.4269\/ajtmh.15-0740","article-title":"A Randomized Comparison of Chloroquine Versus Dihydroartemisinin-Piperaquine for the Treatment of Plasmodium vivax Infection in Vietnam","volume":"94","author":"PD Thuan","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"pmed.1002928.ref035","article-title":"Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria","author":"CS Chu","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"3","key":"pmed.1002928.ref036","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/cid\/ciy065","article-title":"Age-Related Clinical Spectrum of Plasmodium knowlesi Malaria and Predictors of Severity","volume":"67","author":"MJ Grigg","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"3","key":"pmed.1002928.ref037","doi-asserted-by":"crossref","first-page":"677","DOI":"10.4269\/ajtmh.17-0662","article-title":"Therapeutic Response to Dihydroartemisinin-Piperaquine for P. falciparum and P. vivax Nine Years after Its Introduction in Southern Papua, Indonesia","volume":"98","author":"JR Poespoprodjo","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"pmed.1002928.ref038","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1475-2875-9-105","article-title":"Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial","volume":"9","author":"GR Awab","year":"2010","journal-title":"Malar J"},{"key":"pmed.1002928.ref039","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/1475-2875-11-404","article-title":"Efficacy of artemether-lumefantrine as a treatment for uncomplicated Plasmodium vivax malaria in eastern Sudan","volume":"11","author":"TM Abdallah","year":"2012","journal-title":"Malar J"},{"issue":"5","key":"pmed.1002928.ref040","doi-asserted-by":"crossref","first-page":"e63433","DOI":"10.1371\/journal.pone.0063433","article-title":"In vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central Ethiopia","volume":"8","author":"J Hwang","year":"2013","journal-title":"PLoS ONE"},{"issue":"5","key":"pmed.1002928.ref041","doi-asserted-by":"crossref","first-page":"e1002299","DOI":"10.1371\/journal.pmed.1002299","article-title":"Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial","volume":"14","author":"T Abreha","year":"2017","journal-title":"PLoS Med"},{"issue":"1","key":"pmed.1002928.ref042","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12936-018-2192-x","article-title":"Efficacy and safety of artemisinin-based combination therapy and chloroquine with concomitant primaquine to treat Plasmodium vivax malaria in Brazil: an open label randomized clinical trial","volume":"17","author":"A Daher","year":"2018","journal-title":"Malar J"},{"issue":"4","key":"pmed.1002928.ref043","doi-asserted-by":"crossref","first-page":"e0154015","DOI":"10.1371\/journal.pone.0154015","article-title":"G6PD Deficiency and Antimalarial Efficacy for Uncomplicated Malaria in Bangladesh: A Prospective Observational Study","volume":"11","author":"B Ley","year":"2016","journal-title":"PLoS ONE"},{"key":"pmed.1002928.ref044","article-title":"Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria","author":"CS Chu","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pmed.1002928.ref045","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/s12936-017-2034-2","article-title":"Measuring ex vivo drug susceptibility in Plasmodium vivax isolates from Cambodia","volume":"16","author":"S Chaorattanakawee","year":"2017","journal-title":"Malar J"},{"issue":"10","key":"pmed.1002928.ref046","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1128\/AAC.00283-12","article-title":"Comparative ex vivo activity of novel endoperoxides in multidrug-resistant Plasmodium falciparum and P. vivax","volume":"56","author":"J Marfurt","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"pmed.1002928.ref047","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1475-2875-13-73","article-title":"Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondonia, West Amazon, Brazil","volume":"13","author":"AC Aguiar","year":"2014","journal-title":"Malar J"},{"issue":"3","key":"pmed.1002928.ref048","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1128\/AAC.01334-07","article-title":"Determinants of in vitro drug susceptibility testing of Plasmodium vivax","volume":"52","author":"B Russell","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"pmed.1002928.ref049","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/AAC.44.3.697-704.2000","article-title":"Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria","volume":"44","author":"F Ezzet","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"pmed.1002928.ref050","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1128\/AAC.49.12.5127-5128.2005","article-title":"Pitfalls in estimating piperaquine elimination","volume":"49","author":"J Tarning","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"pmed.1002928.ref051","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.1365-2125.2003.02004.x","article-title":"Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria","volume":"57","author":"TY Hung","year":"2004","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"pmed.1002928.ref052","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00003088-199937020-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine","volume":"37","author":"NJ White","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"pmed.1002928.ref053","volume-title":"Coartem: full prescribing information","author":"Novartis","year":"2015"},{"issue":"2","key":"pmed.1002928.ref054","first-page":"301","article-title":"Potentiation of the curative action of primaquine in vivax malaria by quinine and chloroquine","volume":"46","author":"AS Alving","year":"1955","journal-title":"J Lab Clin Med"},{"issue":"5","key":"pmed.1002928.ref055","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02590-16","article-title":"Age, Weight, and CYP2D6 Genotype Are Major Determinants of Primaquine Pharmacokinetics in African Children","volume":"61","author":"BP Goncalves","year":"2017","journal-title":"Antimicrob Agents Chemother"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1002928","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T17:48:49Z","timestamp":1588960129000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1002928"}},"subtitle":[],"editor":[{"given":"Clara","family":"Menendez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,10,4]]},"references-count":55,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1002928","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,4]]}}}